Ji J, Liu Z, Kuang P, Dong T, et al. A new conditioning regimen with chidamide, cladribine, gemcitabine and busulfan significantly improve the outcome of high-risk or relapsed/refractory non-Hodgkin's lymphomas. Int J Cancer 2021;149:2075-2082.
PMID: 34398971